Martijn L T M Müller Selected Research

Cholinergic Agents (Cholinergics)

1/2022	Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson's disease: correlation with postural and gait deficits.
1/2022	Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment.
1/2021	Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.
1/2021	Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.
1/2021	α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.
12/2020	New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders.
1/2020	Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs.
1/2019	Cholinergic system changes of falls and freezing of gait in Parkinson's disease.
1/2019	The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.
1/2019	Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martijn L T M Müller Research Topics

Disease

39	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2010
14	Dementia (Dementias) 01/2020 - 06/2010
8	Cognitive Dysfunction 01/2022 - 06/2010
4	Alzheimer Disease (Alzheimer's Disease) 03/2018 - 04/2012
3	Hypokinesia (Bradykinesia) 01/2022 - 05/2013
3	Parkinsonian Disorders (Parkinsonism) 12/2020 - 04/2012
2	Tremor (Tremors) 01/2021 - 05/2013
2	Hallucinations (Hallucination) 01/2020 - 01/2018
2	REM Sleep Behavior Disorder 02/2015 - 04/2012
2	Leukoaraiosis 12/2014 - 05/2013
2	Movement Disorders (Movement Disorder) 04/2014 - 12/2012
1	Prodromal Symptoms 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Dyskinesias (Dyskinesia) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2012
1	Leukoencephalopathies 08/2011
1	Anosmia 06/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010

Drug/Important Bio-Agent (IBA)

26	Cholinergic Agents (Cholinergics)IBA 01/2022 - 06/2010
9	dihydrotetrabenazineIBA 12/2014 - 06/2010
7	AcetylcholinesteraseIBA 01/2019 - 06/2010
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2010
5	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2019 - 06/2010
5	Amyloid (Amyloid Fibrils)IBA 01/2017 - 09/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2013
3	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2022 - 01/2020
3	fluoroethoxy-benzovesamicolIBA 01/2022 - 01/2020
3	PropionatesIBA 10/2013 - 06/2010
2	LigandsIBA 01/2022 - 12/2012
2	Cholinergic ReceptorsIBA 01/2021 - 03/2018
2	Levodopa (L Dopa)FDA LinkGeneric 05/2013 - 04/2012
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 03/2013 - 12/2012
2	Serotonin (5 Hydroxytryptamine)IBA 12/2012 - 01/2012
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	SynucleinsIBA 04/2013
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2013
1	CarbonIBA 12/2012
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2012
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2012

Therapy/Procedure

21	Denervation 01/2021 - 02/2010
2	Therapeutics 01/2018 - 12/2014